New coronavirus cases continue to surge around the world. In fact, according to MarketWatch, global cases are now above 204 million, with the death toll above 4.31 million. In the U.S. alone, there’s a total of 36 million cases with 618,137 deaths, with the delta variant making its way around the country. Worse, the seven-day average case load is up to 118,067, up 86% in two weeks. Even schools around the country are struggling with higher pandemic numbers, forcing some to rethink their opening strategies. With virus numbers on the rise — even in vaccinated countries — the world is bracing for many more cases, which could substantially increase the need for contact tracing. That said, some of the top companies to keep an eye on include Contakt World Technologies (CSE:HELP)(OTC:TLOOF)(FWB:B21), which is committed to improving health equity and disease management while solving sector-specific business challenges, Laboratory Corp. of America Holdings (NYSE:LH), Abbott Laboratories (NYSE:ABT), Quest Diagnostics (NYSE:DGX), Chembio Diagnostics (NASDAQ:CEMI).
Look at Contakt World Technologies (CSE:HELP)(OTC:TLOOF)(FWB:B21) for example
Contakt World Technologies a SaaS company committed to improving health equity and disease management while solving sector specific business challenges, today announced it has acquired Stratum Health Solutions, LLC, which operates HealthCheck by StratumTM, an encrypted wellness tracking and analytics tool with 1,000+ current customers. Contakt World acquired Stratum from RTAE Holdings LLC.
HealthCheck is a secure, cloud-based platform that allows organizations of all sizes to track and evaluate employee and student health and Covid-19 related symptoms in real-time through an app. Following strict data privacy laws, HealthCheck's intuitive digital portal enables users to participate in a health self-assessment based on CDC guidelines, where they answer a series of health-based questions at any point in the day, better preparing for current Covid-19 and future health outbreaks while protecting the overall health of the organization against Covid-19 and other threats.
HealthCheck is used by a variety of customers including schools, hospitals, fire stations, financial institutions, and small businesses. HealthCheck has 1,000+ customers, including over 50,000 users within Atlanta Public Schools across 91 learning sites. Contakt World hopes to rapidly scale the consumption of HealthCheck services through its partner network, including the National Association of County and City Health Officials and Satcher Health Leadership Institute, Morehouse School of Medicine.
Health Check generated US$1.23M in revenue over the last 12 months with US$0.44M in net income during the same period. A 20% increase in revenue was observed between the last 6 months and the previous 6-month period.
“With HealthCheck’s daily health check-ins, when people show symptoms for Covid-19, the participating organization immediately receives alerts and access to their user’s unique health dashboard,” said Justin Beck, Chief Visionary Officer of Contakt World. “The technology is a valuable addition to our product and service portfolio, anchored by Smart Health RM. We believe HealthCheck will serve as an excellent sales channel for Contakt World’s other solutions, given HealthCheck’s existing 1,000+ customers, and the app provides a potential avenue for Contakt World to incorporate vaccine passports in our product suite.”
“With schools opening again and the delta variant making clear that we may face Covid-19 and viruses like the flu for the foreseeable future, it’s clear that organizations of all sizes will need ways to conduct symptoms checks, testing, waivers and more to reduce risks. We view HealthCheck as a way to solve the most pressing public health challenge of today in Covid-19, and to prepare for unpredictable threats tomorrow might bring,” concluded Beck.
Ryan Trimberger, Stratum Co-Founder and Chief Executive Officer added, “Contakt World’s global technology platform attracted us as an ideal venue to offer HealthCheck. We were led to create HealthCheck in response to the global Covid-19 pandemic and the urgent need for organizations to make informed safety and operational decisions to keep people healthy, leveraging our expertise in cloud-based technology. Through this acquisition, we’re now shareholders in Contakt World, and believe their team is well positioned to leverage and scale HealthCheck to global prominence through their relationships in public health and healthcare.”
Other related developments from around the markets include:
Laboratory Corp. of America Holdings, a leading global life sciences company announced that Pixel by Labcorp® COVID-19 PCR Test Home Collection Kits are now in 6,000 Walgreens stores nationwide and through Walgreens collaborations with on-demand delivery services DoorDash and Instacart. The newly expanded availability and delivery option advances Walgreens and Labcorp’s efforts to increase COVID-19 testing access in communities across the U.S., especially in underserved areas.
Abbott Laboratories announced it has received CE Mark for its Panbio™ COVID-19 Antigen Self-Test for sale directly to consumers for use in the detection of the SARS-CoV-2 virus in adults and children with or without symptoms. This over-the-counter approval paves the way for critical access to fast, reliable self-testing throughout Europe to reduce the spread of infection as economies reopen and daily life activities resume. Frequent rapid testing at work, school, home and other facilities makes it possible for people to know their infection status when it matters most – making mass screening an essential tool in the mitigation of COVID-19 as restrictions lift and vaccines roll out. According to a recent study published in JAMA, at least 50% of COVID-19 infections are estimated to have originated from exposure to asymptomatic individuals. 1
Quest Diagnostics Inc. and eMed, a telehealth company democratizing healthcare through digital-point-of-care solutionsare collaborating to bring clinician-guided rapid antigen testing for COVID-19 to employers seeking to foster safer environments by decreasing the risk of COVID-19 exposure in their workplaces. Through the collaboration, the two companies will leverage the BinaxNOW™ COVID-19 Ag Card Home Test, a self-administered, nasal swab antigen test that provides results in 15 minutes. An eMed Certified Guide supervises the testing process virtually, confirming employee identity, overseeing proper sample collection, and authenticating results during a telehealth visit.
Chembio Diagnostics Inc. , a leading point-of-care diagnostics company focused on infectious diseases, reported financial results for the quarter ended June 30, 2021. “In the second quarter, we focused on international commercial opportunities where our DPP COVID test has been approved. These efforts were successful, resulting in the largest order in company history for DPP SARS-CoV-2 Antigen tests from our longstanding customer Bio-Manguinhos. We also made progress on our clinical activity to support U.S. regulatory submissions for our DPP COVID-19 tests,” said Richard Eberly, Chembio’s President and Chief Executive Officer. “Looking forward, we believe the investments we have made in product development, expanding our commercial infrastructure and our automated manufacturing operations position us for future success. The recently raised capital has strengthened the balance sheet and will support execution of our strategic initiatives.”
Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice.Contakt World Technologies has paid three thousand five hundred dollars for advertising and marketing services to be distributed by Winning Media. Winning Media is only compensated for its services in the form of cash-based compensation. Winning Media owns ZERO shares of Contakt World Technologies. Please click here for full disclaimer.
Contact Information:
2818047972
[email protected]
